The Adderall Crisis No One’s Talking About -

How DEA Policy Quietly Altered Our Medication and Our Lives

By Marilynn Monroe

For years, many people with ADHD such as myself have relied on Adderall to bring our scattered minds into focus — not for a “high,” but for stability, clarity, and basic functionality.

Over the last few years, that stability has crumbled. Pharmacies ran dry. Medications that once worked perfectly began feeling unpredictable — sometimes weak, causing debilitating side effects that we’ve never experienced before, and other times didn’t work at all or provide any therapeutic benefit. Patients were left gaslighting themselves as well as being gaslit by their doctors and pharmacists who claim, “All generics are created equal.” This left many of us wondering “Is it me, or did my meds change?”

Now, the evidence proves it hasn’t all been in our heads, but most likely due to a DEA policy change.

The DEA has failed to account for medical demand and formulation science, and ignored repeated signals (from Congress, FDA, physicians, and patients).

The Hidden Shift That Broke the System

In 2021, under former DEA Administrator Anne Milgram, the agency quietly changed how it allocates the raw ingredients used to make Adderall.

Instead of approving production quotas that matched Adderall’s true chemical balance — roughly 75% d-amphetamine and 25% l-amphetamine (a 3:1 ratio) — the DEA began dividing the quotas equally between these two isomers. That’s a 1:1 split — the opposite of what manufacturers actually need to produce legitimate Adderall.

This bureaucratic miscalculation cut off manufacturers from the correct ingredients, forcing them to ration or alter production. Even if the official formula stayed the same, the end product patients received was anything but consistent.

🔗 House Oversight Committee letter to DEA (May 13 2024) — the Committee specifically questions DEA’s 1:1 isomer allocation policy.

What the Paper Trail Shows

2021–2025: DEA quota tables begin listing separate lines for “d-amphetamine (for sale)”, “l-amphetamine (for sale)”, and “d,l-amphetamine (for sale)”, confirming an internal policy shift toward isomer-specific quotas.
🔗 DEA Aggregate Production Quota (APQ) History 2015–2025
May 2024: House Oversight Committee letter demands records on how DEA allocates amphetamine isomers and whether that contributed to shortages.
April 2025: DEA’s own conference presentation — “Quotas – Online Applications & Changes” — confirms manufacturers must apply separately for d-, l-, and d,l-amphetamine quotas. The slides claim the goal is to “help prevent and alleviate shortages,” indirectly acknowledging that earlier quota systems worsened them.
July 2025: DEA press release confirms Terry Cole sworn in as Administrator after Anne Milgram’s tenure.
October 2 2025: In the Federal Register, DEA officially raises the 2025 Aggregate Production Quota for d-amphetamine (for sale) from 21.2 metric tons → 26.45 metric tons, citing an active-ingredient shortage.
🔗 Federal Register Vol. 90 No. 191 (Oct 2 2025)

The Human Cost

For most people, this may not seem like a big deal. After all, ADHD medication isn’t considered, “life saving” according to the general population. Contrary to popular belief, this class of medication is in fact life altering and gives those who have ADHD a real chance at a decent quality of life. We are talking about actual human beings whose lives have unraveled over the last few years because of the inconsistent quality of our medications thanks to this policy change. To those of us who rely on this medication to function, it’s years of our lives we’ll never get back.

We’ve lost jobs, academic progress, emotional regulation, and self-trust. We were told it was “supply chain issues,” “your tolerance has gone up” or “you just have to wait it out.” Meanwhile, millions have cycled through withdrawal, exhaustion, and despair — watching the very medication that once anchored us slip further from reach.

The DEA didn’t technically “change the formula.” But by restricting the key ingredient, they changed the outcome of our medications. They altered the balance of our medication in practice in an attempt to combat diversion and abuse— and they changed thousands of lives for the worse in the process.

My Open Letter to the DEA and Congress

“The DEA may not have changed Adderall’s formula on paper, but by starving manufacturers of the right ingredients, they changed the medication in practice — and millions of lives in the process.

This was a bureaucratic failure with a human cost: years of cognitive instability, withdrawal, lost jobs, and broken trust in treatment systems.”

— Marilynn B. Monroe

Official_Open_Letter_to_DEA_and_Congress_MarilynnBMonroe

What Needs to Happen Next

Transparency: DEA must release year-by-year quota allocations for d- and l-amphetamine from 2016–2020 and compare these to the allocations for 2021-present.
Accountability: Congress must investigate how and why quota policies ignored medical ratios. We also demand answers as to what these drug manufacturers have been replacing the missing ingredients with and why no one has owned up to it yet.
Coordination: FDA + DEA must align quota policy with approved drug formulations with total transparency to physicians and patients alike that actually meet demand. The restrictions on the current quota system are unrealistic.
Awareness: Patients and doctors deserve to know this wasn’t in our heads or random — it was avoidable. Due to the massive overreach of the DEA in recent years who were trying to prevent diversion and abuse to a fault, negatively affected those of us who genuinely need this medication to function.

If You’ve Been Affected

You are not crazy and you are not alone in this. You deserve answers. We’ve been stripped of our quality of life which isn’t anything to bat an eye at.

Take action:

Share this post with the hashtags #AdderallCrisis and #ADHDmedshortage
Report medication inconsistencies to FDA MedWatch
Email your representatives (find them here)“I’m requesting an investigation into DEA quota mismanagement that contributed to the national Adderall shortage.”
If you’ve been affected, share your story in the comment section below

Closing Thoughts

For a few years now, I’ve written about mental health and rebuilding self-trust. This topic hits home for me. It makes me angry, mourning the last few years of my life that I have been living in pure survival mode instead of actually being able to thrive.

This is all thanks to the sudden inconsistency of my medication (Adderall IR) that I genuinely need to function and have a decent quality of life. Stability seems like a foreign concept to those of us who have been struggling behind the scenes with shortages, inconsistent batch quality from month to month, being labeled as addicts, dealing with ridiculous insurance policies that also delay our treatment. If you pile all of this stress on top of the fact that our medication isn’t manufactured the way it used to be? It feels like an endless nightmare we can’t wake up from.

This isn’t a crazy conspiracy theory of mine. It is a prime example of carelessness and massive overreach. Carelessness at this scale is cruelty.

I refuse to stay silent on this matter. I will continue to search for answers and utilize my outrage to motivate me to keep pushing forward for anyone else who’s been affected by this crisis.

The only way any of this will change is if we refuse to stay silent and demand better. There is strength in numbers. I know if you’re reading this, you’re just as angry, defeated and exhausted as I am. Use what little motivation you may have to reach out to your representatives. We may not see change overnight, but I assure you, if we are persistent, they can’t block us out forever.

If you would like to reach out with your stories on how this crisis has directly affected you or a loved one, please feel free to leave a comment below or reach out to me here: connect@marilynnmonroe.com

📚 Source Index

Acknowledgment

This research and article would not have been possible without the insight and persistence of a fellow member of the ADHD community on Reddit, u/Odd-Ask642, whose careful analysis and documentation helped connect many of the dots about the DEA quota changes. Her dedication to uncovering the truth inspired me to bring this story together and share it publicly.

Alex

November 17, 2025 at

THANK YOU FOR WRITING AND SHARING THIS!!!! That’s all my poorly medicated ADHD brain can articulate at this moment, but I wanted to make sure to thank you for how well you laid this all out.

Marilynn Monroe
November 18, 2025 at

Absolutely! I know it’s been difficult for those of us who depend on this medication to maintain a decent quality of life.